Danish companies join forces to compete for global talent
Novo Nordisk is one of 15 large enterprises joining forces in a new initiative - Consortium for Global Talent - to improve employment terms to attract and not least retain highly skilled foreigners. The initiative has been set up to help highlight some of the practical and financial obstacles that may deter global talent from choosing Denmark as their next workplace.
"It is crucial for a global company such as Novo Nordisk to be able to bring in the brightest minds from around the world to work for enterprises headquartered in Denmark. But to attract and retain the best of the best we know that it is not only the job that needs to be appealing, but the whole 'package' has to work. It is not only a question of tax and financial issues, but just as much about whether their children are able to attend an international school and their spouse can be granted a work permit or driving licence without too many problems," explains Lars Christian Lassen, senior vice president, Corporate People & Organisation at Novo Nordisk.
Large Danish companies are currently facing these challenges on a daily basis which is why it will be the main task of the consortium to focus on possible solutions and to coordinate its plan with the many public and private initiatives and schemes on offer.
Link to the Novo Nordisk jobsite: http://www.novonordisk.com/jobs/Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 29,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.